Genotropin and Type 1 diabetes - a phase IV clinical study of FDA data

Summary:

Type 1 diabetes is reported as a side effect among people who take Genotropin (somatropin recombinant), especially for people who are female, 10-19 old, have been taking the drug for 1 - 6 months also take Ddavp, and have Hypopituitarism.

The phase IV clinical study analyzes which people have Type 1 diabetes when taking Genotropin. It is created by eHealthMe based on reports of 41,867 people who have side effects when taking Genotropin from the FDA, and is updated regularly.

What is Genotropin?

Genotropin has active ingredients of somatropin recombinant. It is often used in growth hormone deficiency. eHealthMe is studying from 41,924 Genotropin users. Check the latest studies of Genotropin.

What is Type 1 diabetes?

Type 1 diabetes is found to be associated with 668 drugs and 1,644 conditions by eHealthMe. Check the latest studies of Type 1 diabetes.

On Aug, 02, 2026

41,867 people reported to have side effects when taking Genotropin.
Among them, 27 people (0.06%) have Type 1 diabetes.

Among these 27 people:

How long have people been on Genotropin when they have Type 1 diabetes? *

What is the gender of people who have Type 1 diabetes when taking Genotropin? *

female: 52.38 %
male: 47.62 %

What is the age of people who have Type 1 diabetes when taking Genotropin? *

What are other drugs people take besides Genotropin? *

Novorapid: 2 people, 7.41%
Hydrocortisone: 2 people, 7.41%
Ddavp: 2 people, 7.41%

What are other side effects people have besides Type 1 diabetes? *

Diabetic Ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies): 4 people, 14.81%
Blood Glucose Increased: 3 people, 11.11%
Thyroid Diseases: 2 people, 7.41%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 2 people, 7.41%
Hypoglycemia (low blood sugar): 2 people, 7.41%
Disease Recurrence: 2 people, 7.41%
Weight Decreased: 1 person, 3.70%
Urination - Excessive Volume: 1 person, 3.70%
Thirst - Excessive: 1 person, 3.70%
Scoliosis (a medical condition in which a person's spine is curved from side to side): 1 person, 3.70%

What are the existing conditions these people have? *

Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 5 people, 18.52%
Growth Retardation (delayed growth): 4 people, 14.81%

* Approximation only. Some reports may have incomplete information.

Do you take Genotropin and have Type 1 diabetes?

- Check whether Type 1 diabetes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Genotropin:

Genotropin (41,924 reports)

Type 1 diabetes treatments and more:

Type 1 diabetes (46,846 reports)

Browse all side effects of Genotropin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Type 1 diabetes:

Type 1 diabetes (668 drugs)

Browse all the conditions that are associated with Type 1 diabetes:

Type 1 diabetes (1,644 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on somatropin recombinant (the active ingredients of Genotropin) and Genotropin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.